OTC Market

What is Supporting Strong Growth of the U.S. OTC Market?

Driven by the market return of popular OTC brands from Johnson & Johnson and GlaxoSmithKline, as well as the success of several Rx-to-OTC switch brands, the U.S. OTC market increases by a solid 4% in 2015, reveals our recently published Nonprescription Drugs USA report.

In October 2015, Johnson & Johnson announced that the FDA approved the reopening of the Fort Washington, PA, plant that had been shuttered since May  2010. Johnson & Johnson’s key brands, including Tylenol Arthritis Pain and Tylenol 8 Hour, are re-launched in 2015, supporting overall sales growth of the OTC drugs market. Steady distribution of Zyrtec and other key brands from the market leader, Johnson & Johnson, help propel sales in the OTC market.Continue reading

Nonprescription Drugs USA Webinar

Free Webinar: Drivers of the U.S. OTC Drug Market

Recent switches, the return of major brands that had been previously recalled, and branded innovations continue to drive the nonprescription drugs market in the United Sates. Above-average growth rates within some categories are propelled by newly switched brands being launched, which are bringing prescription users to the OTC market.

During this live webinar, Sai Swaroop, Kline’s Senior Consultant, will reveal some interesting key findings from our recently published Nonprescription Drugs USA report. The session will take place on Tuesday, July 12, 2016 at 11:00 AM EDT | 17:00 PM CET.Continue reading